Doxorubicin cardiotoxicity and the protective effects of exercise
阿霉素心脏毒性和运动的保护作用
基本信息
- 批准号:10166985
- 负责人:
- 金额:$ 3.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AnthracyclineAttenuatedBiologicalBlood VesselsCancer PatientCardiacCardiac MyocytesCardiomyopathiesCardiotoxicityCarrier ProteinsCell DeathClinicalConsensusCytochrome c ReductaseDevelopmentDoxorubicinEndotheliumEventExerciseFoundationsFree RadicalsFutureGoalsHeartIronLeadMalignant NeoplasmsMediatingMitochondriaMolecularMyocardialMyocardial dysfunctionOxidation-ReductionPathologyPermeabilityPlayPrevalencePreventionPrevention strategyProductionRisk FactorsRoleSolid NeoplasmTestingTherapeuticTight JunctionsTissuesToxic effectVascular PermeabilitiesXenobioticsanti-cancercardiovascular disorder riskchemotherapeutic agentendurance exerciseexercise trainingheart functionheart preservationmitochondrial dysfunctionoutcome forecastpreventprotective effectsolutetranslational study
项目摘要
PROJECT SUMMARY
Doxorubicin (DOX) is a highly effective anticancer anthracycline used in the treatment of a wide variety of solid
tumor malignancies. However, clinical use of this powerful chemotherapeutic is limited by the prevalence of
irreversible cardiac tissue damage, which carries a poor prognosis and is often fatal. While efforts have been
made to identify risk factors, develop less-toxic derivatives and detect subclinical toxicity earlier, there is currently
no consensus on the best approach to prevent anthracycline-induced cardiomyopathy. Thus, further advances
in the understanding of the molecular basis of DOX-induced pathology are needed to generate preventative
strategies. DOX accumulates rapidly within cardiac tissue following exposure, where it preferentially localizes to
the mitochondria and promotes free radical production through redox cycling with NADH dehydrogenase and
iron cycling between Fe2+ and Fe3+. Elevated free radical production in the mitochondria can lead to severe
damaging events resulting in cell death, and evidence suggests that prevention of mitochondrial dysfunction is
sufficient to attenuate the cardiotoxic effects of DOX. Therefore, elucidating ways in which the mitochondrial
accumulation of DOX can be reduced could result in the development of a therapeutic approach to mitigate the
cardiotoxic effects of DOX. In this regard, we recently discovered that endurance exercise training prior to DOX
treatment is sufficient to reduce the mitochondrial accumulation of DOX and preserve cardiac function. While the
mechanisms responsible for the exercise-induced reduction in the levels of cardiac mitochondrial DOX are
unknown, we hypothesize that activity-induced changes in the expression of xenobiotic transport proteins and/or
changes in vascular tight junction integrity may play a role in mediating the entry of DOX into the cardiomyocytes.
Therefore, the goal of this proposal is to establish the effects of exercise training on the expression of solute
carrier transport proteins and on vascular permeability, and to determine if targeting these mechanisms has
therapeutic potential to prevent DOX-induced cardiac dysfunction. We will accomplish this by testing the
following specific aims: Specific Aim 1) will determine the effects of exercise and doxorubicin on the expression
of solute carrier proteins in the heart; and Specific Aim 2) will determine if exercise-induced protection against
DOX cardiotoxicity is related to changes in endothelial function and tight junction permeability.
项目摘要
多柔比星(DOX)是一种高效的抗癌蒽环类抗生素,用于治疗各种各样的固体肿瘤。
恶性肿瘤然而,这种强大的化疗药物的临床使用受到以下流行病的限制:
不可逆转的心脏组织损伤,预后不良,往往是致命的。虽然努力
为了识别风险因素,开发毒性较小的衍生物,并更早地检测亚临床毒性,目前
对于预防蒽环类药物引起的心肌病的最佳方法没有达成共识。因此,进一步的进展
在理解DOX诱导的病理学的分子基础上,
战略布局DOX在暴露后在心脏组织内迅速积累,在那里它优先定位于
线粒体和促进自由基的生产,通过氧化还原循环与NADH脱氢酶,
铁在Fe 2+和Fe 3+之间循环。线粒体中自由基产生的增加可导致严重的
破坏性事件导致细胞死亡,有证据表明,预防线粒体功能障碍是
足以减弱DOX的心脏毒性作用。因此,阐明线粒体
DOX的积累可以减少,这可能导致开发一种治疗方法来减轻
DOX的心脏毒性作用在这方面,我们最近发现,耐力运动训练之前,DOX
治疗足以减少DOX的线粒体积累并保护心脏功能。而
运动引起的心肌线粒体DOX水平降低的机制是
未知,我们假设活性诱导的外源性转运蛋白和/或
血管紧密连接完整性的变化可能在介导DOX进入心肌细胞中起作用。
因此,本研究的目的是建立运动训练对溶质表达的影响,
载体转运蛋白和血管通透性,并确定是否针对这些机制,
预防DOX诱导的心功能障碍的治疗潜力。我们将通过测试
具体目标1)将确定运动和阿霉素对表达的影响,
的溶质载体蛋白在心脏;和具体目标2)将确定是否运动诱导的保护,
DOX心脏毒性与内皮功能和紧密连接通透性的变化有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashley Smuder其他文献
Ashley Smuder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashley Smuder', 18)}}的其他基金
Doxorubicin cardiotoxicity and the protective effects of exercise
阿霉素心脏毒性和运动的保护作用
- 批准号:
10162657 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise
阿霉素引起的呼吸功能障碍及运动的保护作用
- 批准号:
9983347 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise
阿霉素引起的呼吸功能障碍及运动的保护作用
- 批准号:
10449081 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise
阿霉素引起的呼吸功能障碍及运动的保护作用
- 批准号:
9922788 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
Doxorubicin cardiotoxicity and the protective effects of exercise
阿霉素心脏毒性和运动的保护作用
- 批准号:
10386915 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
Doxorubicin cardiotoxicity and the protective effects of exercise
阿霉素心脏毒性和运动的保护作用
- 批准号:
9897610 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
Doxorubicin cardiotoxicity and the protective effects of exercise
阿霉素心脏毒性和运动的保护作用
- 批准号:
9986064 - 财政年份:2019
- 资助金额:
$ 3.98万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 3.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 3.98万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
Idea to Innovation














{{item.name}}会员




